Grand Challenges Annual Meeting to Include MB Presentation
Singletto to Partner with Kenyan Healthcare Organizations on TB Research
Singletto Launches ProGear+Oxafence Masks in New Zealand
aPDI Method Proven Effective Against Norovirus, Coronaviruses, and Ebola, Lassa, and Nipah Viruses, according to WHO and Global Researchers, Including Singletto Co-Founders
Canadian Healthcare Facilities Magazine: Dyes, Light, and Oxygen by Singletto CEO John Bjornson
Singletto Launches Oxafence Mask Spray in New Zealand
Protective Dye Methylene Blue Plus Light Proven to Inactivate "Hard-to-kill" Norovirus
It all begins with an idea.
Infection Control & Hospital Epidemiology Publishes Drs. Lendvay, Chen, et al. WHO-led DeMaND Study
Top Doctor 2021: Singletto’s Lendvay Named by Seattle Magazine
It all begins with an idea.